25 XP   0   0   10

Repro Med Systems Inc
Buy, Hold or Sell?

Let's analyse Repro Med Systems Inc together

PenkeI guess you are interested in Repro Med Systems Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Repro Med Systems Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Repro Med Systems Inc

I send you an email if I find something interesting about Repro Med Systems Inc.

Quick analysis of Repro Med Systems Inc (30 sec.)










What can you expect buying and holding a share of Repro Med Systems Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$0.45
Expected worth in 1 year
$0.21
How sure are you?
57.5%

+ What do you gain per year?

Total Gains per Share
$-0.24
Return On Investment
-11.7%

For what price can you sell your share?

Current Price per Share
$2.06
Expected price per share
$2 - $2.53
How sure are you?
50%

1. Valuation of Repro Med Systems Inc (5 min.)




Live pricePrice per Share (EOD)

$2.06

Intrinsic Value Per Share

$-0.78 - $2.90

Total Value Per Share

$-0.33 - $3.35

2. Growth of Repro Med Systems Inc (5 min.)




Is Repro Med Systems Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$20.3m$32.8m-$6.3m-24.2%

How much money is Repro Med Systems Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.4m-$2.1m-$1.2m-37.0%
Net Profit Margin-48.0%-32.0%--

How much money comes from the company's main activities?

3. Financial Health of Repro Med Systems Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#134 / 171

Most Revenue
#130 / 171

Most Profit
#129 / 171

Most Efficient
#138 / 171

What can you expect buying and holding a share of Repro Med Systems Inc? (5 min.)

Welcome investor! Repro Med Systems Inc's management wants to use your money to grow the business. In return you get a share of Repro Med Systems Inc.

What can you expect buying and holding a share of Repro Med Systems Inc?

First you should know what it really means to hold a share of Repro Med Systems Inc. And how you can make/lose money.

Speculation

The Price per Share of Repro Med Systems Inc is $2.06. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Repro Med Systems Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Repro Med Systems Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.45. Based on the TTM, the Book Value Change Per Share is $-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Repro Med Systems Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.16-7.9%-0.08-3.6%-0.05-2.3%-0.03-1.5%-0.01-0.7%
Usd Book Value Change Per Share-0.15-7.5%-0.06-2.9%-0.03-1.4%0.010.6%0.010.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.031.5%0.020.7%
Usd Total Gains Per Share-0.15-7.5%-0.06-2.9%-0.03-1.4%0.042.1%0.021.2%
Usd Price Per Share2.46-3.21-2.80-4.13-2.40-
Price to Earnings Ratio-3.76--15.53--16.05--28.82--11.85-
Price-to-Total Gains Ratio-15.86--104.76--264.08-26.01-4.58-
Price to Book Ratio5.51-5.52-3.91-8.72-6.43-
Price-to-Total Gains Ratio-15.86--104.76--264.08-26.01-4.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.06
Number of shares485
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share-0.060.01
Usd Total Gains Per Share-0.060.04
Gains per Quarter (485 shares)-29.1021.01
Gains per Year (485 shares)-116.4284.04
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-116-126602474
20-233-24212048158
30-349-35818073242
40-466-47423997326
50-582-590299121410
60-699-706359145494
70-815-822419169578
80-931-938479193662
90-1048-1054539218746
100-1164-1170599242830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%18.022.00.045.0%50.046.00.052.1%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%8.012.00.040.0%22.018.00.055.0%54.041.01.056.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%3.00.017.015.0%3.00.037.07.5%15.00.081.015.6%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%9.011.00.045.0%23.017.00.057.5%55.040.01.057.3%

Fundamentals of Repro Med Systems Inc

About Repro Med Systems Inc

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Fundamental data was last updated by Penke on 2024-04-11 12:48:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Repro Med Systems Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Repro Med Systems Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Repro Med Systems Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -103.9% means that $-1.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Repro Med Systems Inc:

  • The MRQ is -103.9%. The company is making a huge loss. -2
  • The TTM is -48.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-103.9%TTM-48.0%-55.9%
TTM-48.0%YOY-32.0%-16.0%
TTM-48.0%5Y-20.7%-27.3%
5Y-20.7%10Y-8.2%-12.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-103.9%6.3%-110.2%
TTM-48.0%6.5%-54.5%
YOY-32.0%8.2%-40.2%
5Y-20.7%7.3%-28.0%
10Y-8.2%7.6%-15.8%
1.1.2. Return on Assets

Shows how efficient Repro Med Systems Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Repro Med Systems Inc to the Medical Instruments & Supplies industry mean.
  • -26.2% Return on Assets means that Repro Med Systems Inc generated $-0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Repro Med Systems Inc:

  • The MRQ is -26.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.2%TTM-10.8%-15.4%
TTM-10.8%YOY-5.1%-5.8%
TTM-10.8%5Y-3.6%-7.3%
5Y-3.6%10Y-0.9%-2.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.2%1.3%-27.5%
TTM-10.8%1.4%-12.2%
YOY-5.1%2.0%-7.1%
5Y-3.6%2.2%-5.8%
10Y-0.9%2.0%-2.9%
1.1.3. Return on Equity

Shows how efficient Repro Med Systems Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Repro Med Systems Inc to the Medical Instruments & Supplies industry mean.
  • -36.7% Return on Equity means Repro Med Systems Inc generated $-0.37 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Repro Med Systems Inc:

  • The MRQ is -36.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.7%TTM-14.7%-22.0%
TTM-14.7%YOY-6.6%-8.1%
TTM-14.7%5Y-4.6%-10.0%
5Y-4.6%10Y-1.2%-3.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.7%2.6%-39.3%
TTM-14.7%2.9%-17.6%
YOY-6.6%3.9%-10.5%
5Y-4.6%3.9%-8.5%
10Y-1.2%4.0%-5.2%

1.2. Operating Efficiency of Repro Med Systems Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Repro Med Systems Inc is operating .

  • Measures how much profit Repro Med Systems Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Repro Med Systems Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -30.6% means the company generated $-0.31  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Repro Med Systems Inc:

  • The MRQ is -30.6%. The company is operating very inefficient. -2
  • The TTM is -35.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-30.6%TTM-35.8%+5.2%
TTM-35.8%YOY-39.6%+3.9%
TTM-35.8%5Y-14.6%-21.1%
5Y-14.6%10Y-4.0%-10.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.6%7.9%-38.5%
TTM-35.8%7.6%-43.4%
YOY-39.6%11.4%-51.0%
5Y-14.6%10.2%-24.8%
10Y-4.0%10.7%-14.7%
1.2.2. Operating Ratio

Measures how efficient Repro Med Systems Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are $1.31 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Repro Med Systems Inc:

  • The MRQ is 1.306. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.360. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.306TTM1.360-0.054
TTM1.360YOY1.398-0.038
TTM1.3605Y1.176+0.184
5Y1.17610Y1.056+0.120
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3061.133+0.173
TTM1.3601.124+0.236
YOY1.3981.082+0.316
5Y1.1761.101+0.075
10Y1.0561.056+0.000

1.3. Liquidity of Repro Med Systems Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Repro Med Systems Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 4.55 means the company has $4.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Repro Med Systems Inc:

  • The MRQ is 4.548. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.197. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.548TTM5.197-0.649
TTM5.197YOY5.468-0.271
TTM5.1975Y6.285-1.088
5Y6.28510Y6.189+0.096
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5482.320+2.228
TTM5.1972.382+2.815
YOY5.4682.575+2.893
5Y6.2852.627+3.658
10Y6.1892.623+3.566
1.3.2. Quick Ratio

Measures if Repro Med Systems Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Repro Med Systems Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 3.49 means the company can pay off $3.49 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Repro Med Systems Inc:

  • The MRQ is 3.492. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.772. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.492TTM3.772-0.280
TTM3.772YOY4.093-0.321
TTM3.7725Y4.870-1.098
5Y4.87010Y4.772+0.098
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4921.111+2.381
TTM3.7721.137+2.635
YOY4.0931.286+2.807
5Y4.8701.423+3.447
10Y4.7721.521+3.251

1.4. Solvency of Repro Med Systems Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Repro Med Systems Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Repro Med Systems Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.28 means that Repro Med Systems Inc assets are financed with 28.5% credit (debt) and the remaining percentage (100% - 28.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Repro Med Systems Inc:

  • The MRQ is 0.285. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.237. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.285TTM0.237+0.048
TTM0.237YOY0.232+0.005
TTM0.2375Y0.187+0.050
5Y0.18710Y0.175+0.013
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2850.351-0.066
TTM0.2370.357-0.120
YOY0.2320.357-0.125
5Y0.1870.359-0.172
10Y0.1750.371-0.196
1.4.2. Debt to Equity Ratio

Measures if Repro Med Systems Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Repro Med Systems Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 39.8% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Repro Med Systems Inc:

  • The MRQ is 0.398. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.313. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.398TTM0.313+0.085
TTM0.313YOY0.304+0.009
TTM0.3135Y0.237+0.076
5Y0.23710Y0.215+0.021
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3980.541-0.143
TTM0.3130.559-0.246
YOY0.3040.545-0.241
5Y0.2370.610-0.373
10Y0.2150.669-0.454

2. Market Valuation of Repro Med Systems Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Repro Med Systems Inc generates.

  • Above 15 is considered overpriced but always compare Repro Med Systems Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -3.76 means the investor is paying $-3.76 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Repro Med Systems Inc:

  • The EOD is -3.153. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.758. Based on the earnings, the company is expensive. -2
  • The TTM is -15.527. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.153MRQ-3.758+0.605
MRQ-3.758TTM-15.527+11.769
TTM-15.527YOY-16.052+0.525
TTM-15.5275Y-28.822+13.295
5Y-28.82210Y-11.848-16.974
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-3.15314.638-17.791
MRQ-3.75817.745-21.503
TTM-15.52718.883-34.410
YOY-16.05222.272-38.324
5Y-28.82220.830-49.652
10Y-11.84825.069-36.917
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Repro Med Systems Inc:

  • The EOD is 26.498. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 31.578. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -37.626. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.498MRQ31.578-5.081
MRQ31.578TTM-37.626+69.205
TTM-37.626YOY1.815-39.442
TTM-37.6265Y-179.914+142.288
5Y-179.91410Y-88.973-90.941
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD26.49810.196+16.302
MRQ31.57810.068+21.510
TTM-37.6261.502-39.128
YOY1.8153.822-2.007
5Y-179.9147.817-187.731
10Y-88.9730.759-89.732
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Repro Med Systems Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 5.51 means the investor is paying $5.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Repro Med Systems Inc:

  • The EOD is 4.626. Based on the equity, the company is fair priced.
  • The MRQ is 5.513. Based on the equity, the company is overpriced. -1
  • The TTM is 5.525. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.626MRQ5.513-0.887
MRQ5.513TTM5.525-0.011
TTM5.525YOY3.912+1.613
TTM5.5255Y8.718-3.194
5Y8.71810Y6.427+2.291
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD4.6262.427+2.199
MRQ5.5132.782+2.731
TTM5.5252.828+2.697
YOY3.9123.290+0.622
5Y8.7183.530+5.188
10Y6.4274.227+2.200
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Repro Med Systems Inc.

3.1. Institutions holding Repro Med Systems Inc

Institutions are holding 58.64% of the shares of Repro Med Systems Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31First Light Asset Management, LLC11.30681.01995163737-123559-2.3369
2023-12-31Archon Capital Management LLC8.14742.258937208761580244.4353
2023-12-31Vanguard Group Inc4.1820.00011909874212861.1271
2023-12-31BlackRock Inc3.68570.000116832341233177.9054
2023-12-31B. Riley Asset Management, LLC1.80540.7598824534-9129-1.095
2023-12-31Albion Financial Group (Utah)1.68350.1556768854-23855-3.0093
2023-12-31Geode Capital Management, LLC1.66740.0002761484246023.3387
2023-12-31Meros Investment Management, LP1.15120.6125525764103682.0117
2023-12-31State Street Corporation1.06620.0001486906100392.1052
2023-12-31Northern Trust Corp1.06070.000248442218906764.0135
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC0.77320.022135313000
2023-12-31KeyBank National Association0.47350.002421622400
2023-12-31Empire Financial Management Company, LLC0.23430.1028107000-23000-17.6923
2023-12-31Washington Trust Co0.2190.009710000000
2023-12-31Bank of New York Mellon Corp0.21380.00019765400
2023-12-31PNC Financial Services Group Inc0.21240.000297000-878-0.897
2023-12-31Charles Schwab Investment Management Inc0.2030.00019272800
2023-12-31Morgan Stanley - Brokerage Accounts0.16550755923187572.9121
2023-12-31Lakewood Asset Management LLC0.13120.11435992500
2023-12-31White Pine Capital LLC0.12290.053156110-2563-4.3683
Total 38.50515.112217585048+385594+2.2%

3.2. Funds holding Repro Med Systems Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.44920.0002114065100
2024-03-28iShares Russell 2000 ETF1.47220.00256856473300.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.11290.0011518325117002.3094
2024-01-31Fidelity Small Cap Index0.66990.002631199100
2024-03-28iShares Russell 2000 Growth ETF0.59760.0056278315-324-0.1163
2024-02-29Fidelity Extended Market Index0.50020.0013232959-1129-0.4823
2023-12-31Acuitas US Microcap Strategy0.34620.105416124422431.4107
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.32340.000815060000
2024-02-29Vanguard Russell 2000 ETF0.26920.002812536098698.5453
2023-12-31NT R2000 Growth Index Fund - NL0.22640.00710544700
2023-12-31NT R2000 Index Fund - NL0.21720.00341011351730.1714
2023-09-30BlackRock Extended Mkt Composite0.20410.0018950436120.6481
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.18550.00218640000
2024-03-31BlackRock Extended Equity Market K0.17620.001382046300.0366
2024-02-29Schwab Small Cap Index0.17160.00297991500
2023-12-31NT R2000 Index Fund - DC - NL - 20.1710.003479645-170-0.213
2023-12-31Northern Trust Russell 2000 Growth Index0.1630.00677592943366.0565
2023-12-31NT R2000 Growth Index Fund - L0.1630.00677592943366.0565
2024-03-28iShares Micro-Cap ETF0.16090.01927495900
2024-02-29Fidelity Total Market Index0.15440.00027189300
Total 9.73410.1774533433+32006+0.7%

3.3. Insider Transactions

Insiders are holding 5.493% of the shares of Repro Med Systems Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-21Joseph M Jr. MankoBUY100002.65
2023-08-18Joseph M Jr. MankoBUY100002.54
2023-08-18Linda M TharbyBUY52722.53
2023-08-16Robert CascellaBUY190002.61

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Repro Med Systems Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.155-0.060-61%-0.028-82%0.012-1342%0.009-1919%
Book Value Per Share--0.4450.578-23%0.718-38%0.606-26%0.379+17%
Current Ratio--4.5485.197-12%5.468-17%6.285-28%6.189-27%
Debt To Asset Ratio--0.2850.237+20%0.232+23%0.187+52%0.175+63%
Debt To Equity Ratio--0.3980.313+27%0.304+31%0.237+68%0.215+85%
Dividend Per Share----0%-0%0.031-100%0.015-100%
Eps---0.163-0.075-54%-0.047-71%-0.030-82%-0.013-92%
Free Cash Flow Per Share--0.019-0.031+261%-0.045+331%-0.022+215%-0.009+149%
Free Cash Flow To Equity Per Share--0.016-0.032+309%-0.043+379%0.007+138%0.005+244%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.900--------
Intrinsic Value_10Y_min---0.776--------
Intrinsic Value_1Y_max--0.010--------
Intrinsic Value_1Y_min---0.127--------
Intrinsic Value_3Y_max--0.243--------
Intrinsic Value_3Y_min---0.340--------
Intrinsic Value_5Y_max--0.735--------
Intrinsic Value_5Y_min---0.509--------
Market Cap94163630.000-19%112219277.500146559290.625-23%127875123.750-12%189001489.875-41%109926438.820+2%
Net Profit Margin---1.039-0.480-54%-0.320-69%-0.207-80%-0.082-92%
Operating Margin---0.306-0.358+17%-0.396+30%-0.146-52%-0.040-87%
Operating Ratio--1.3061.360-4%1.398-7%1.176+11%1.056+24%
Pb Ratio4.626-19%5.5135.5250%3.912+41%8.718-37%6.427-14%
Pe Ratio-3.153+16%-3.758-15.527+313%-16.052+327%-28.822+667%-11.848+215%
Price Per Share2.060-19%2.4553.206-23%2.798-12%4.135-41%2.405+2%
Price To Free Cash Flow Ratio26.498-19%31.578-37.626+219%1.815+1639%-179.914+670%-88.973+382%
Price To Total Gains Ratio-13.306+16%-15.857-104.758+561%-264.080+1565%26.012-161%4.585-446%
Quick Ratio--3.4923.772-7%4.093-15%4.870-28%4.772-27%
Return On Assets---0.262-0.108-59%-0.051-81%-0.036-86%-0.009-97%
Return On Equity---0.367-0.147-60%-0.066-82%-0.046-87%-0.012-97%
Total Gains Per Share---0.155-0.060-61%-0.028-82%0.043-457%0.024-747%
Usd Book Value--20353771.00026420440.250-23%32810033.750-38%27683312.650-26%17329669.125+17%
Usd Book Value Change Per Share---0.155-0.060-61%-0.028-82%0.012-1342%0.009-1919%
Usd Book Value Per Share--0.4450.578-23%0.718-38%0.606-26%0.379+17%
Usd Dividend Per Share----0%-0%0.031-100%0.015-100%
Usd Eps---0.163-0.075-54%-0.047-71%-0.030-82%-0.013-92%
Usd Free Cash Flow--888417.000-1426787.500+261%-2051529.250+331%-1025870.250+215%-433669.550+149%
Usd Free Cash Flow Per Share--0.019-0.031+261%-0.045+331%-0.022+215%-0.009+149%
Usd Free Cash Flow To Equity Per Share--0.016-0.032+309%-0.043+379%0.007+138%0.005+244%
Usd Market Cap94163630.000-19%112219277.500146559290.625-23%127875123.750-12%189001489.875-41%109926438.820+2%
Usd Price Per Share2.060-19%2.4553.206-23%2.798-12%4.135-41%2.405+2%
Usd Profit---7466029.000-3435265.500-54%-2165285.500-71%-1380637.050-82%-615779.450-92%
Usd Revenue--7185932.0007129416.500+1%6974009.250+3%6362147.350+13%4870530.000+48%
Usd Total Gains Per Share---0.155-0.060-61%-0.028-82%0.043-457%0.024-747%
 EOD+4 -4MRQTTM+11 -22YOY+10 -235Y+8 -2810Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of Repro Med Systems Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.153
Price to Book Ratio (EOD)Between0-14.626
Net Profit Margin (MRQ)Greater than0-1.039
Operating Margin (MRQ)Greater than0-0.306
Quick Ratio (MRQ)Greater than13.492
Current Ratio (MRQ)Greater than14.548
Debt to Asset Ratio (MRQ)Less than10.285
Debt to Equity Ratio (MRQ)Less than10.398
Return on Equity (MRQ)Greater than0.15-0.367
Return on Assets (MRQ)Greater than0.05-0.262
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Repro Med Systems Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.130
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  -435-143-577-23-600300-3005,7455,445
Income Tax Expense  -435-143-577-23-600300-3005,7455,445
Total Other Income Expense Net -1-56-5754-2-10-13190177



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets28,461
Total Liabilities8,107
Total Stockholder Equity20,354
 As reported
Total Liabilities 8,107
Total Stockholder Equity+ 20,354
Total Assets = 28,461

Assets

Total Assets28,461
Total Current Assets20,256
Long-term Assets8,205
Total Current Assets
Cash And Cash Equivalents 11,482
Net Receivables 4,074
Inventory 3,481
Other Current Assets 1,218
Total Current Assets  (as reported)20,256
Total Current Assets  (calculated)20,256
+/- 0
Long-term Assets
Property Plant Equipment 7,352
Long-term Assets Other 99
Long-term Assets  (as reported)8,205
Long-term Assets  (calculated)7,451
+/- 754

Liabilities & Shareholders' Equity

Total Current Liabilities4,454
Long-term Liabilities3,653
Total Stockholder Equity20,354
Total Current Liabilities
Short-term Debt 792
Short Long Term Debt 314
Accounts payable 975
Other Current Liabilities 2,687
Total Current Liabilities  (as reported)4,454
Total Current Liabilities  (calculated)4,769
+/- 314
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,339
Long-term Liabilities  (as reported)3,653
Long-term Liabilities  (calculated)3,339
+/- 314
Total Stockholder Equity
Common Stock491
Retained Earnings -23,312
Other Stockholders Equity 43,175
Total Stockholder Equity (as reported)20,354
Total Stockholder Equity (calculated)20,354
+/-0
Other
Capital Stock491
Cash and Short Term Investments 11,482
Common Stock Shares Outstanding 45,670
Liabilities and Stockholders Equity 28,461
Net Debt -7,037
Net Invested Capital 20,668
Net Working Capital 15,802
Property Plant and Equipment Gross 10,073
Short Long Term Debt Total 4,445



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-30
> Total Assets 
3,500
3,480
3,350
3,560
4,150
4,050
4,030
4,000
3,810
3,610
2,320
2,240
2,090
1,600
1,580
1,622
1,622
1,531
1,510
1,443
1,505
1,482
1,442
1,399
1,371
1,345
1,305
1,111
1,100
1,107
1,016
1,188
1,235
1,128
1,013
980
909
905
928
917
833
1,045
1,020
1,138
1,039
1,140
1,180
1,305
1,367
1,479
1,669
2,310
2,235
2,311
2,391
2,988
3,009
2,909
3,084
3,435
3,735
4,154
4,452
4,805
4,805
5,211
5,402
5,592
5,251
5,429
5,594
6,209
6,671
7,094
7,387
7,281
7,428
7,710
8,194
8,394
8,335
8,343
8,475
8,170
8,004
8,591
9,281
9,360
10,258
10,577
10,545
11,563
11,751
13,717
13,882
16,603
47,711
45,434
39,919
42,374
40,599
41,358
41,293
43,428
42,461
42,666
42,332
38,254
35,996
35,354
28,461
28,46135,35435,99638,25442,33242,66642,46143,42841,29341,35840,59942,37439,91945,43447,71116,60313,88213,71711,75111,56310,54510,57710,2589,3609,2818,5918,0048,1708,4758,3438,3358,3948,1947,7107,4287,2817,3877,0946,6716,2095,5945,4295,2515,5925,4025,2114,8054,8054,4524,1543,7353,4353,0842,9093,0092,9882,3912,3112,2352,3101,6691,4791,3671,3051,1801,1401,0391,1381,0201,0458339179289059099801,0131,1281,2351,1881,0161,1071,1001,1111,3051,3451,3711,3991,4421,4821,5051,4431,5101,5311,6221,6221,5801,6002,0902,2402,3203,6103,8104,0004,0304,0504,1503,5603,3503,4803,500
   > Total Current Assets 
2,100
1,860
1,640
1,760
2,330
2,150
1,880
1,860
1,660
1,450
1,730
1,660
1,530
1,040
1,000
1,100
1,100
980
930
922
954
915
870
830
804
794
773
594
624
643
564
755
811
721
610
571
514
529
569
550
512
740
723
814
753
861
887
988
1,069
1,203
1,393
2,009
1,926
2,013
2,086
2,479
2,567
2,491
2,760
3,015
3,307
3,692
3,902
4,254
4,169
4,312
4,411
4,633
4,275
4,458
4,667
5,295
5,663
5,833
6,032
5,908
6,027
6,381
6,906
7,119
7,051
7,012
7,119
6,780
6,641
7,217
7,929
8,051
8,900
9,128
9,033
9,568
9,929
11,867
11,881
14,480
45,306
42,648
37,526
39,085
37,140
37,661
37,321
33,931
30,968
30,742
29,802
25,215
22,541
21,687
20,256
20,25621,68722,54125,21529,80230,74230,96833,93137,32137,66137,14039,08537,52642,64845,30614,48011,88111,8679,9299,5689,0339,1288,9008,0517,9297,2176,6416,7807,1197,0127,0517,1196,9066,3816,0275,9086,0325,8335,6635,2954,6674,4584,2754,6334,4114,3124,1694,2543,9023,6923,3073,0152,7602,4912,5672,4792,0862,0131,9262,0091,3931,2031,0699888878617538147237405125505695295145716107218117555646436245947737948048308709159549229309801,1001,1001,0001,0401,5301,6601,7301,4501,6601,8601,8802,1502,3301,7601,6401,8602,100
       Cash And Cash Equivalents 
930
1,020
100
110
40
60
160
130
90
110
680
100
220
180
170
136
136
118
48
35
52
63
37
26
55
89
24
17
53
39
17
220
222
133
70
37
17
27
63
27
4
121
93
99
83
70
75
96
133
152
349
519
581
498
577
813
1,054
1,023
1,363
1,322
1,780
1,861
1,820
1,757
1,983
1,940
1,682
1,930
1,633
1,835
1,921
2,227
2,339
2,242
2,248
2,557
2,471
3,157
3,340
4,202
3,861
3,966
3,440
3,313
2,983
3,662
3,975
4,033
3,421
3,649
3,739
2,593
3,807
5,129
5,871
7,428
38,129
32,434
27,315
26,775
26,538
26,233
25,335
22,577
18,266
16,441
17,408
12,225
11,719
10,772
11,482
11,48210,77211,71912,22517,40816,44118,26622,57725,33526,23326,53826,77527,31532,43438,1297,4285,8715,1293,8072,5933,7393,6493,4214,0333,9753,6622,9833,3133,4403,9663,8614,2023,3403,1572,4712,5572,2482,2422,3392,2271,9211,8351,6331,9301,6821,9401,9831,7571,8201,8611,7801,3221,3631,0231,0548135774985815193491521339675708399931214276327173770133222220173953172489552637635235481181361361701802201006801109013016060401101001,020930
       Short-term Investments 
0
0
640
600
580
840
630
470
350
160
80
450
250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255
0
256
256
257
257
258
258
259
259
259
259
260
260
260
260
261
261
261
261
262
262
262
263
159
159
1,671
1,518
1,524
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,5241,5181,6711591592632622622622612612612612602602602602592592592592582582572572562560255000000000000000000000000000000000000000000000000002504508016035047063084058060064000
       Net Receivables 
350
120
150
210
820
310
230
320
240
150
120
320
150
280
230
241
241
169
193
208
202
180
151
191
169
131
182
184
191
198
151
130
208
156
113
125
115
121
143
148
105
167
194
214
182
252
287
297
326
411
414
489
355
479
523
655
484
406
352
714
612
609
878
885
737
962
1,188
1,115
944
1,043
1,278
1,745
1,654
1,617
1,709
1,624
1,475
1,409
1,758
1,350
1,354
1,345
1,661
1,674
1,900
1,481
1,862
1,855
1,840
1,511
1,426
2,655
3,293
3,547
3,235
3,420
2,966
3,737
2,573
3,561
2,577
3,123
4,311
3,825
4,766
5,756
4,531
5,179
4,771
4,864
4,074
4,0744,8644,7715,1794,5315,7564,7663,8254,3113,1232,5773,5612,5733,7372,9663,4203,2353,5473,2932,6551,4261,5111,8401,8551,8621,4811,9001,6741,6611,3451,3541,3501,7581,4091,4751,6241,7091,6171,6541,7451,2781,0439441,1151,188962737885878609612714352406484655523479355489414411326297287252182214194167105148143121115125113156208130151198191184182131169191151180202208193169241241230280150320120150240320230310820210150120350
       Inventory 
580
520
520
630
680
730
630
710
750
790
570
540
650
490
560
626
626
646
641
587
609
644
650
601
562
544
530
382
361
390
369
379
350
381
383
372
357
358
337
347
372
423
402
490
462
513
496
551
575
564
562
622
641
708
738
635
627
633
689
668
830
1,090
1,062
1,167
1,317
1,251
1,170
1,150
1,263
1,107
956
819
1,025
1,441
1,571
1,227
1,413
1,296
1,259
1,040
1,124
1,074
1,299
1,354
1,267
1,587
1,659
1,801
1,718
1,949
2,104
2,509
2,572
2,739
2,388
3,089
3,667
5,633
6,830
8,059
7,563
6,968
6,106
6,018
6,772
6,884
6,405
6,638
5,278
4,677
3,481
3,4814,6775,2786,6386,4056,8846,7726,0186,1066,9687,5638,0596,8305,6333,6673,0892,3882,7392,5722,5092,1041,9491,7181,8011,6591,5871,2671,3541,2991,0741,1241,0401,2591,2961,4131,2271,5711,4411,0258199561,1071,2631,1501,1701,2511,3171,1671,0621,090830668689633627635738708641622562564575551496513462490402423372347337358357372383381350379369390361382530544562601650644609587641646626626560490650540570790750710630730680630520520580
   > Long-term Assets 
1,400
1,620
1,710
1,800
1,820
1,900
2,150
2,140
2,150
2,160
590
580
560
560
580
522
522
551
579
522
550
566
573
569
567
551
532
517
476
464
451
433
423
407
403
410
395
376
359
367
321
305
297
325
286
278
293
317
298
276
276
301
309
299
305
509
442
418
324
419
428
462
549
552
636
900
990
959
976
971
927
913
1,008
1,260
1,355
1,373
1,402
1,329
1,287
1,276
1,284
1,331
1,356
1,391
1,363
1,374
1,320
1,310
1,359
1,449
1,512
1,996
1,822
1,850
2,001
2,123
2,404
2,786
2,393
3,289
3,459
3,697
3,972
9,496
11,493
11,924
12,531
13,039
13,455
13,668
8,205
8,20513,66813,45513,03912,53111,92411,4939,4963,9723,6973,4593,2892,3932,7862,4042,1232,0011,8501,8221,9961,5121,4491,3591,3101,3201,3741,3631,3911,3561,3311,2841,2761,2871,3291,4021,3731,3551,2601,0089139279719769599909006365525494624284193244184425093052993093012762762983172932782863252973053213673593763954104034074234334514644765175325515675695735665505225795515225225805605605805902,1602,1502,1402,1501,9001,8201,8001,7101,6201,400
       Property Plant Equipment 
1,310
1,550
1,620
1,660
1,680
1,710
1,720
1,710
1,680
1,660
520
510
500
500
480
469
469
458
488
472
458
475
482
468
468
451
434
416
399
384
370
358
349
335
333
338
321
303
286
268
251
237
228
221
208
197
213
236
219
201
202
228
237
227
232
221
218
266
264
361
372
407
495
499
581
845
912
876
890
898
855
839
872
1,112
1,196
1,161
1,156
1,106
1,046
997
985
968
934
932
901
902
836
774
795
821
859
1,305
1,055
1,044
986
979
1,124
1,532
1,404
1,356
1,277
1,291
1,202
6,073
7,363
7,515
7,674
7,613
7,438
7,365
7,352
7,3527,3657,4387,6137,6747,5157,3636,0731,2021,2911,2771,3561,4041,5321,1249799861,0441,0551,3058598217957748369029019329349689859971,0461,1061,1561,1611,1961,1128728398558988908769128455814994954073723612642662182212322272372282022012192362131972082212282372512682863033213383333353493583703843994164344514684684824754584724884584694694805005005105201,6601,6801,7101,7201,7101,6801,6601,6201,5501,310
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
9
9
9
9
9
8
9
9
9
9
9
9
9
9
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000009999999998999999900000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45
45
0
0
48
48
0
0
44
44
47
0
35
35
33
32
41
41
42
44
43
44
43
38
37
36
35
35
36
35
33
31
31
30
28
27
26
25
23
23
22
23
26
42
41
43
105
117
128
181
214
192
210
248
267
331
391
427
430
441
484
504
532
596
632
671
747
786
807
873
927
885
844
844
835
821
809
795
792
799
787
783
773
758
0
075877378378779979279580982183584484488592787380778674767163259653250448444143042739133126724821019221418112811710543414226232223232526272830313133353635353637384344434442414132333535047444400484800454500000000000000000000000000
       Long-term Assets Other 
90
70
90
140
140
190
430
430
470
500
70
70
60
60
100
53
53
93
91
50
93
91
90
101
100
100
98
56
77
80
82
28
74
72
71
28
28
73
74
55
28
28
69
55
28
28
28
28
28
28
28
28
28
28
0
0
28
28
28
28
28
28
28
28
31
31
56
60
60
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
32
32
-1,320
32
32
32
20
20
20
20
20
20
20
20
20
20
20
20
20
90
89
89
103
99
99
99
99
9999999910389899020202020202020202020202020323232-1,3203232313131313131313131313131313131606056313128282828282828280028282828282828282828556928285574732828717274288280775698100100101909193509193535310060607070500470430430190140140907090
> Total Liabilities 
1,200
1,210
1,180
1,450
1,800
1,810
2,160
2,120
2,080
2,020
1,780
1,850
1,850
1,090
920
927
927
815
811
749
912
947
999
1,062
1,084
1,079
1,074
1,049
1,068
1,150
1,133
1,362
1,387
1,387
1,393
1,498
1,531
1,574
1,441
1,487
1,540
1,765
1,718
1,784
1,794
1,843
1,782
1,690
1,683
1,491
1,485
1,605
1,466
1,333
1,357
1,299
1,232
950
957
954
1,057
1,034
1,153
1,254
1,164
1,220
1,314
1,236
780
828
805
1,017
1,289
1,202
1,396
1,008
1,212
1,152
1,423
1,276
1,393
1,540
1,739
1,494
979
1,255
1,586
1,241
1,566
1,437
1,584
2,393
2,246
2,708
2,646
4,471
8,463
5,493
3,762
4,591
3,335
4,560
4,792
8,627
9,840
10,174
11,006
8,458
7,895
7,924
8,107
8,1077,9247,8958,45811,00610,1749,8408,6274,7924,5603,3354,5913,7625,4938,4634,4712,6462,7082,2462,3931,5841,4371,5661,2411,5861,2559791,4941,7391,5401,3931,2761,4231,1521,2121,0081,3961,2021,2891,0178058287801,2361,3141,2201,1641,2541,1531,0341,0579549579501,2321,2991,3571,3331,4661,6051,4851,4911,6831,6901,7821,8431,7941,7841,7181,7651,5401,4871,4411,5741,5311,4981,3931,3871,3871,3621,1331,1501,0681,0491,0741,0791,0841,0629999479127498118159279279201,0901,8501,8501,7802,0202,0802,1202,1601,8101,8001,4501,1801,2101,200
   > Total Current Liabilities 
200
220
190
460
420
460
800
810
800
860
880
970
1,040
680
270
528
528
296
345
341
513
526
574
647
668
675
680
560
699
795
790
650
585
593
609
723
687
738
618
664
723
579
588
659
675
729
674
1,039
1,038
853
854
720
597
477
514
495
544
278
300
314
433
427
562
559
485
558
670
525
469
523
506
772
1,049
968
1,192
692
904
852
1,141
1,108
1,245
1,414
1,628
1,389
869
1,154
1,586
1,217
1,545
1,405
1,584
2,027
1,875
2,304
2,406
4,268
8,296
5,361
3,666
4,531
3,311
4,560
4,792
4,713
5,730
6,167
6,959
4,524
4,077
4,222
4,454
4,4544,2224,0774,5246,9596,1675,7304,7134,7924,5603,3114,5313,6665,3618,2964,2682,4062,3041,8752,0271,5841,4051,5451,2171,5861,1548691,3891,6281,4141,2451,1081,1418529046921,1929681,0497725065234695256705584855595624274333143002785444955144775977208548531,0381,0396747296756595885797236646187386877236095935856507907956995606806756686475745265133413452965285282706801,040970880860800810800460420460190220200
       Short-term Debt 
0
0
0
260
90
160
360
480
480
480
440
370
360
0
0
0
0
84
84
81
186
217
222
291
317
284
332
226
368
352
373
225
223
221
221
225
221
221
219
215
260
50
80
72
67
68
88
419
417
414
384
122
123
40
43
66
139
40
40
2
42
42
43
43
44
2
2
45
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136
138
139
142
1,643
3,643
143
144
144
143
805
604
651
430
1,052
877
667
454
925
792
7929254546678771,0524306516048051431441441433,6431,6431421391381360000000000000000000000444522444343424224040139664340123122384414417419886867728050260215219221221225221221223225373352368226332284317291222217186818484000036037044048048048036016090260000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
132
0
0
0
1,500
3,500
0
0
0
0
673
509
256
0
645
433
218
0
466
314
3144660218433645025650967300003,5001,5000001320000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
143
99
138
102
157
132
169
189
198
225
264
268
258
318
328
326
269
270
293
348
345
396
277
307
318
326
367
443
443
481
401
342
333
149
151
219
135
135
137
81
74
72
68
158
132
172
310
200
227
113
203
110
197
249
206
247
520
432
679
243
397
310
522
308
0
710
911
772
279
363
454
550
712
592
453
943
530
875
573
1,097
920
1,363
625
1,916
1,006
1,385
1,228
1,268
2,390
1,366
2,392
1,503
1,575
946
975
9759461,5751,5032,3921,3662,3901,2681,2281,3851,0061,9166251,3639201,097573875530943453592712550454363279772911710030852231039724367943252024720624919711020311322720031017213215868727481137135135219151149333342401481443443367326318307277396345348293270269326328318258268264225198189169132157102138991430000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
385
198
123
158
170
177
183
167
153
166
84
67
73
125
89
99
93
102
96
150
120
121
122
142
146
203
141
144
165
180
186
277
288
291
320
356
317
279
312
326
308
144
169
263
474
380
373
587
384
842
464
694
250
252
277
503
506
513
491
426
484
520
596
778
0
681
695
594
567
769
1,131
647
818
803
1,127
948
1,207
1,290
1,691
1,528
3,733
3,855
2,898
2,472
2,162
2,370
2,870
2,794
241
357
257
262
263
501
2,687
2,6875012632622573572412,7942,8702,3702,1622,4722,8983,8553,7331,5281,6911,2901,2079481,1278038186471,1317695675946956810778596520484426491513506503277252250694464842384587373380474263169144308326312279317356320291288277186180165144141203146142122121120150961029399891257367841661531671831771701581231983850000000000000000
   > Long-term Liabilities 
1,000
990
990
990
1,380
1,350
1,360
1,310
1,280
1,160
900
880
810
410
650
399
399
518
466
408
399
421
424
415
416
404
394
489
368
355
343
712
802
794
784
775
845
836
823
823
817
1,186
1,130
1,125
1,119
1,114
1,108
651
645
638
631
885
869
856
843
804
688
672
656
640
624
608
591
696
679
662
645
710
311
305
300
245
239
234
203
316
308
300
282
168
147
127
110
105
110
100
20
24
21
33
457
366
371
405
239
203
168
132
96
60
24
2,190
1,922
3,914
4,110
4,007
4,048
3,933
3,818
3,702
3,653
3,6533,7023,8183,9334,0484,0074,1103,9141,9222,190246096132168203239405371366457332124201001101051101271471682823003083162032342392453003053117106456626796965916086246406566726888048438568698856316386456511,1081,1141,1191,1251,1301,1868178238238368457757847948027123433553684893944044164154244213994084665183993996504108108809001,1601,2801,3101,3601,3501,3809909909901,000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000230010000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33
0
24
65
133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000133652403300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
695
717
699
694
592
535
444
337
287
265
231
61
32
-43
-117
-173
-152
-259
-380
-518
-622
-669
-513
-570
-707
-720
-699
-646
-756
-703
-602
-385
-316
-12
184
705
769
978
1,034
1,689
1,777
1,959
2,127
2,480
2,678
3,120
3,299
3,551
3,641
3,992
4,087
4,357
4,471
4,601
4,789
5,192
5,383
5,892
5,991
6,273
6,216
6,558
6,771
7,118
0
6,803
6,736
6,676
7,025
7,337
7,670
8,119
8,693
9,140
8,961
9,171
9,505
11,009
11,236
12,132
39,247
39,941
36,157
37,783
37,264
36,798
36,501
34,801
32,621
32,492
31,326
29,796
28,101
27,431
20,354
20,35427,43128,10129,79631,32632,49232,62134,80136,50136,79837,26437,78336,15739,94139,24712,13211,23611,0099,5059,1718,9619,1408,6938,1197,6707,3377,0256,6766,7366,80307,1186,7716,5586,2166,2735,9915,8925,3835,1924,7894,6014,4714,3574,0873,9923,6413,5513,2993,1202,6782,4802,1271,9591,7771,6891,034978769705184-12-316-385-602-703-756-646-699-720-707-570-513-669-622-518-380-259-152-173-117-4332612312652873374445355926946997176950000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
234
235
235
235
235
235
235
235
235
235
235
235
235
235
236
245
249
249
249
260
269
269
281
290
304
306
308
310
328
353
328
348
348
348
348
348
348
356
356
356
356
365
365
366
366
386
386
375
375
389
389
389
389
389
389
389
394
404
404
403
403
403
403
405
0
405
405
406
406
407
407
408
409
409
409
409
411
422
422
424
466
467
467
479
479
479
480
481
484
487
489
490
490
491
491
49149149049048948748448148047947947946746746642442242241140940940940940840740740640640540504054034034034034044043943893893893893893893893753753863863663663653653563563563563483483483483483483283533283103083063042902812692692602492492492452362352352352352352352352352352352352352352340000000000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,653
2,377
1,252
158
-910
-3,448
-6,369
-7,594
-9,571
-11,982
-14,478
0
0
00-14,478-11,982-9,571-7,594-6,369-3,448-9101581,2522,3773,65300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000-1,888-1,876-1,890-1,819-1,793-1,767-1,760-1,705-1,689-1,641-1,5790-1,452-1,404-1,319-1,261-1,201-1,170-1,113-1,078-1,025-975-915-91500-1,827-1,82700-1,602-1,60200-1,415-1,386-1,360-1,338-1,317-1,300-1,285-1,271-1,257-1,243-1,229-1,214-1,197-1,179-1,161-1,144-1,127-1,096-1,096-1,081-1,066-1,006-1,006-1,006-1,006-934-934-934-934-915-896-877-858-840-821-802-784-766-747-728-708-10-21-31-41-612-590-570-570000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,595
4,890
5,145
5,986
6,293
6,738
0
0
35,881
38,771
39,376
40,004
40,774
41,611
42,350
43,443
44,252
45,132
45,932
0
0
0045,93245,13244,25243,44342,35041,61140,77440,00439,37638,77135,881006,7386,2935,9865,1454,8904,595000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00-3,844-3,844-3,844-3,844-3,844-3,844-3,844-3,844-3,844-3,844-3,84400-344-344-344-344-344-344000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,912
1,911
1,911
4,139
4,139
4,139
4,139
2,070
2,070
2,070
2,070
2,070
2,070
2,070
2,071
2,111
2,127
2,117
2,117
2,161
2,194
2,195
2,269
2,304
2,360
2,369
2,446
2,471
2,522
2,500
2,566
2,704
2,709
2,737
2,742
2,771
2,771
2,866
2,866
2,866
2,866
2,869
2,869
2,876
2,876
3,179
3,176
3,121
3,121
3,107
3,147
3,187
3,228
3,267
3,293
3,319
3,347
3,643
3,650
3,633
3,640
3,647
3,692
3,693
0
3,694
3,731
3,786
3,774
3,818
3,873
3,918
4,014
4,075
4,251
4,546
4,801
5,641
5,949
6,393
34,543
34,987
32,037
34,928
35,533
36,161
36,931
37,767
38,506
39,600
40,409
41,289
42,089
42,786
43,175
43,17542,78642,08941,28940,40939,60038,50637,76736,93136,16135,53334,92832,03734,98734,5436,3935,9495,6414,8014,5464,2514,0754,0143,9183,8733,8183,7743,7863,7313,69403,6933,6923,6473,6403,6333,6503,6433,3473,3193,2933,2673,2283,1873,1473,1073,1213,1213,1763,1792,8762,8762,8692,8692,8662,8662,8662,8662,7712,7712,7422,7372,7092,7042,5662,5002,5222,4712,4462,3692,3602,3042,2692,1952,1942,1612,1172,1172,1272,1112,0712,0702,0702,0702,0702,0702,0702,0704,1394,1394,1394,1391,9111,9111,9120000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue28,518
Cost of Revenue-12,680
Gross Profit15,83815,838
 
Operating Income (+$)
Gross Profit15,838
Operating Expense-26,108
Operating Income-10,270-10,270
 
Operating Expense (+$)
Research Development5,742
Selling General Administrative20,366
Selling And Marketing Expenses0
Operating Expense26,10826,108
 
Net Interest Income (+$)
Interest Income561
Interest Expense-0
Other Finance Cost-0
Net Interest Income561
 
Pretax Income (+$)
Operating Income-10,270
Net Interest Income561
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,774-10,766
EBIT - interestExpense = -10,270
-9,774
-13,741
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-10,270-9,774
Earnings Before Interest and Taxes (EBITDA)-9,400
 
After tax Income (+$)
Income Before Tax-9,774
Tax Provision-3,967
Net Income From Continuing Ops-13,741-13,741
Net Income-13,741
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses38,788
Total Other Income/Expenses Net496-561
 

Technical Analysis of Repro Med Systems Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Repro Med Systems Inc. The general trend of Repro Med Systems Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Repro Med Systems Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Repro Med Systems Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.52 < 2.53 < 2.53.

The bearish price targets are: 2.04 > 2.01 > 2.

Tweet this
Repro Med Systems Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Repro Med Systems Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Repro Med Systems Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Repro Med Systems Inc.

Repro Med Systems Inc Daily Moving Average Convergence/Divergence (MACD) ChartRepro Med Systems Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Repro Med Systems Inc. The current adx is .

Repro Med Systems Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Repro Med Systems Inc.

Repro Med Systems Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Repro Med Systems Inc.

Repro Med Systems Inc Daily Relative Strength Index (RSI) ChartRepro Med Systems Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Repro Med Systems Inc.

Repro Med Systems Inc Daily Stochastic Oscillator ChartRepro Med Systems Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Repro Med Systems Inc.

Repro Med Systems Inc Daily Commodity Channel Index (CCI) ChartRepro Med Systems Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Repro Med Systems Inc.

Repro Med Systems Inc Daily Chande Momentum Oscillator (CMO) ChartRepro Med Systems Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Repro Med Systems Inc.

Repro Med Systems Inc Daily Williams %R ChartRepro Med Systems Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Repro Med Systems Inc.

Repro Med Systems Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Repro Med Systems Inc.

Repro Med Systems Inc Daily Average True Range (ATR) ChartRepro Med Systems Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Repro Med Systems Inc.

Repro Med Systems Inc Daily On-Balance Volume (OBV) ChartRepro Med Systems Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Repro Med Systems Inc.

Repro Med Systems Inc Daily Money Flow Index (MFI) ChartRepro Med Systems Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Repro Med Systems Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Repro Med Systems Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Repro Med Systems Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.130
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Repro Med Systems Inc with someone you think should read this too:
  • Are you bullish or bearish on Repro Med Systems Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Repro Med Systems Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Repro Med Systems Inc

I send you an email if I find something interesting about Repro Med Systems Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Repro Med Systems Inc.

Receive notifications about Repro Med Systems Inc in your mailbox!